SFRMBM 2023
Miguel Guevara1, Davy Cam4, Jacques Badagbon4, Stéphane Roche4, Michel Bottlaender3, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort4 and Alexandre Vignaud1,2[…]
Read moreMiguel Guevara1, Davy Cam4, Jacques Badagbon4, Stéphane Roche4, Michel Bottlaender3, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort4 and Alexandre Vignaud1,2[…]
Read moreQSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2, Davy Cam3, Jacques Badagbon3, Michel Bottlaender2, Yann[…]
Read moreJournée mondiale Alzheimer 2022 Ventio participe au suivi des patients atteints par la maladie d’Alzheimer en proposant une technologie brevetée,[…]
Read moreQuantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai,[…]
Read moreImaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-François Mangin, Alexandre Vignaud, Cyril[…]
Read moreDecreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audrey, Roche, Stéphane, Gény, Christian, Bennys, Karim, Labauge,[…]
Read moreCorrelations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle,[…]
Read morePreanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Roche, Y. Allory, A. Barthelaix, J.-L. Beaudeux, F.[…]
Read more